Xenon Pharmaceuticals, Inc. (XENE)
NGM · Common · CUSIP 98420N105
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for XENE and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
98420N105
Market Cap
Small Cap
IPO
11/4/2014 · $9.00/share
Business: Xenon Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company discovering and developing a pipeline of differentiated therapeutics for orphan indications. It has an integrated platform, which includes in-house capabilities for human genetics, small molecule drug discovery, and preclinical and clinical development.

Company Contact

CEO
Ian Mortimer
CFO
Tucker Kelly
Headquarters
200 - 3650 Gilmore Way, Burnaby, British Columbia, Canada V5G 4W8
Phone
604-484-3300
Fax
604-484-3450
Investor Relations
Ian Mortimer · 604-484-3319 · investors@xenon-pharma.com
Email Form
Contact Form »
SEC EDGAR Filings
View filings »
SEDAR+ Filings
Go to SEDAR+ »